Skip to content
CT
Company

Updated:

Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics International, Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001333763, and its...

Overview

Chelsea Therapeutics International, Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001333763, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2014-03-11, it reported net income of USD -16,416,233; total assets of USD 46,502,522 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Chelsea Therapeutics International, Ltd.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Charlotte, NC, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001333763

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2013USD-$16.4M$46.5M$45.3M—
FY2012USD-$31.7M$28.9M$28.4M-$39.4M
FY2011USD-$50.5M$46.9M$41.1M-$48.0M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K CURRENT REPORT
SC 13G—Form SC 13G
8-KFORM 8-K
10-QFORM 10-Q
8-KFORM 8-K
10-K/AFORM 10-K/A
10-KFORM 10-K
8-KFORM 8K
SC 13G—SC 13G
8-K8-K CURRENT REPORT
8-KFORM 8-K
SC 13G—Form SC 13G

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Chelsea Therapeutics International, Ltd. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Chelsea Therapeutics International, Ltd. | Company | Altss